What started as a simple quest, less than 10 years ago, by 2 scientists, for some clues to an unusual observation of nature at the apex of its performance, has evolved into one of the most daring and progressive scientific project in the fight against cancer.

In the early 90’s, Drs. Adam Telerman and Robert Amson observed a rare natural phenomenon, where a few cancer cells succeeded in quitting their tumorous state to revert to a suppressed-malignant phenotype.
When the first revertant cell clone was isolated and validated in 1993,
Tumor Reversion, a concept until then, became a scientific reality.

Tumor Reversion is the natural mechanism by which a selected few cells have learned by themselves how to suppress, at a molecular level, their malignant phenotype. It has also become the main research engine of our scientific cancer project.